[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,434
Sort by:
EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. engages in the production, marketing, and sale of pharmaceutical, veterinary, and health care products primarily in Turkey. It also procures and sells person...

March 2020 50 pages
ALK-Abelló A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ALK-Abello A/S, a pharmaceutical company, engages in the development and sale of products for the diagnosis, prevention, and treatment of allergies. The company offers GRAZAX, an allergy vaccination t...

March 2020 50 pages
Advanced Viral Research Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Viral Research Corp., a biopharmaceutical company, focuses on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerati...

March 2020 50 pages
Advanced Proteome Therapeutics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Proteome Therapeutics Corporation, a development stage biotechnology company, through its subsidiary, Advanced Proteome Therapeutics, Inc., focuses on the development and commercialization of...

March 2020 50 pages
Advanced Life Sciences Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the areas of infectious disease, oncology, and respiratory...

March 2020 50 pages
Advanced Cell Technology Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. Opera...

March 2020 50 pages
Adolor Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adolor Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription pain management products. ENTEREG (alvimopan) The company's primary produc...

March 2020 50 pages
Adimmune Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adimmune Corporation engages in the development, manufacture, and distribution of human vaccines in Taiwan. It offers vaccines, diagnostics, and biological products. The company’s primary products inc...

March 2020 50 pages
Adherex Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adherex Technologies Inc. operates as a development stage biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. Products The company ha...

March 2020 50 pages
Adeona Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adeona Pharmaceuticals, Inc., a pharmaceutical company, develops medicines for serious central nervous systems diseases. Product Candidates Trimesta: Trimesta (estriol) is an investigational oral drug...

March 2020 50 pages
Addex Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Addex Pharmaceuticals Ltd. focuses on the discovery, development, and commercialization of small molecule pharmaceutical products for the treatment of human health. Its product candidates include ADX4...

March 2020 50 pages
Adcock Ingram Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adcock Ingram Holdings Limited manufactures and sells prescription, generic, and OTC products. It offers a portfolio of branded and generic medicines in various therapeutic categories, including aller...

March 2020 50 pages
Adamis Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adamis Pharmaceuticals Corporation, a specialty pharmaceutical company, develops patented vaccine technology to provide protection against various viral infectious agents. The company primarily offers...

March 2020 50 pages
Acuvax Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acuvax Limited engages in the research and development of cancer therapies and vaccines in Australia and North America. The company’s main business activities include a 28% ownership in Hawaii Biotech...

March 2020 50 pages
Acusphere Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acusphere, Inc., a specialty pharmaceutical company, develops drugs and improved formulations of existing drugs using its proprietary microparticle technology. The company's main product, Imagify (per...

March 2020 50 pages
Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of product candidates providing abuse deterrent features and benefits utilizing i...

March 2020 50 pages
ActiveCare, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ActiveCare, Inc. manufactures and sells medical diagnostic equipment, and laboratory stains and solutions. Product The company's primary product is ActiveOne device, which is a patented mobile persona...

March 2020 50 pages
Active Biotech AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Active Biotech AB, a biotechnology company, focuses on the research and development of drugs for the treatment of cancer and autoimmune/inflammatory diseases. Its projects in clinical development incl...

March 2020 50 pages
Actinogen Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Actinogen Limited operates as a biotechnology company in Australia. The company specializes in the detection and isolation of soil actinomycetes that are found in Western Australia, and the semi-purif...

March 2020 50 pages
Actelion Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Actelion, Ltd., a biopharmaceutical company, engages in the discovery, development and commercialization of treatments to serve high unmet medical needs. The company operates primarily in Switzerland,...

March 2020 50 pages
Acrux Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acrux Limited, a drug delivery company, engages in developing and commercializing a range of patient-preferred, patented pharmaceutical products for global markets, using its technology to administer...

March 2020 50 pages
Acron Genomics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acrongenomics, Inc., a development stage company, focuses on the research and development in the field of life science, including BioLED technology, which combines microfluidics and polymer Light Emit...

March 2020 50 pages
Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acorda Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of therapies that improve neurological function in people wit...

March 2020 50 pages
Acino Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acino Holding Ltd., together with its subsidiaries, engages in the development, registration, and manufacture of generic and patent-protected pharmaceuticals using drug delivery technologies. It provi...

March 2020 50 pages
Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of innovative treatments for infectious diseases. Drug Candidate Pipeline The...

March 2020 50 pages
Access Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Access Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing a range of pharmaceutical products primarily based upon its nanopolymer chemistry technologies and other drug delivery...

March 2020 50 pages
Accentia Biopharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of late-stage, targeted therapeutic clinical products. The company has three products i...

March 2020 50 pages
Accelrys Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accelrys, Inc. engages in the development and commercialize of scientific business intelligence software and solutions that enable its customers to accelerate the discovery and development of drugs an...

March 2020 50 pages
Accelr8 Technology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accelr8 Technology Corporation focuses on the development and commercialization of an integrated system to identify bacteria and their mechanisms of antibiotic resistance in critically ill patients. P...

March 2020 50 pages
Accelerator Nordic AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Founded in 1993, Optovent is a Swedish medical company specialising in monitoring and diagnostic systems. The company produces equipment for situations where the observing of patients is vital, yet no...

March 2020 50 pages
Accel Transmatic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accel Transmatic Limited provides offshore services in product development, embedded systems, and application software development in India. Its Technologies division provides software development ser...

March 2020 50 pages
ACADIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Product Candid...

March 2020 50 pages
Abviva, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abviva, Inc., a biomedical corporation, focuses on the development and commercialization of breast cancer diagnostic and therapeutic products derived from a human biological secreted protein, Mammasta...

March 2020 50 pages
Abnova (Taiwan) Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abnova (Taiwan) Corporation engages in biotechnology service industry in Taipei, Taiwan. It engages in the research and development of individual antibody reagent, individual antibody wafer or protein...

March 2020 50 pages
Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Ablynx NV, a biopharmaceutical company, focuses on the discovery and development of Nanobodies, a class of therapeutic proteins based on single-domain antibody fragments for a range of serious and lif...

March 2020 50 pages
ABL Bio-Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ABL Biotechnologies Limited engages in the identification and extraction of bio-chemicals, primarily from microbes in India. Its products are used as nutritional, cosmetic, pharmaceutical, and industr...

March 2020 50 pages
Abcam Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abcam plc, together with its subsidiaries, engages in developing, marketing, and selling antibodies and related products worldwide. The company primarily offers primary and secondary antibodies, isoty...

March 2020 50 pages
Abbott Laboratories (Pakistan) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott Laboratories (Pakistan) Limited, a healthcare company, engages in the manufacture, import, and marketing of pharmaceutical, nutritional, diagnostic, diabetes care, molecular, hospital, and cons...

March 2020 50 pages
Abbott Laboratories Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company’s segments include Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products...

March 2020 72 pages
Abbott India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott India Limited engages in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products in India. The company offers its products in th...

March 2020 50 pages
AB Science S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicine in the United States and E...

March 2020 50 pages
Aastrom Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aastrom Biosciences, Inc., a development stage regenerative medicine company, focuses on the development of cell therapies to repair or regenerate damaged or diseased tissues. Clinical Development Pro...

March 2020 50 pages
Aarti Drugs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aarti Drugs Limited engages in the manufacture and sale of bulk drugs and its intermediates in India and internationally. It offers various active pharmaceutical ingredients in the therapeutic categor...

March 2020 50 pages
Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aarey Drugs & Pharmaceuticals Limited manufactures, supplies, and exports pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, active pharmaceutical ingredient drugs, food colours, an...

March 2020 50 pages
A.L. Industrier ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

A.L. Industrier ASA engages in the ownership, management, and rental of real estate properties in Oslo, Norway. Its property portfolio comprises office, manufacturing, and warehouse facilities. The co...

March 2020 50 pages
Advaxis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advaxis, Inc., a development stage biotechnology company, develops cancer vaccines that utilize multiple mechanisms of immunity. Products The company is developing a live Listeria vaccine technology u...

March 2020 50 pages
Adventrx Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ADVENTRX Pharmaceuticals, Inc., a developmental stage biopharmaceutical company, engages in developing, in-licensing, and commercializing proprietary product candidates for the treatment of cancer. Pr...

March 2020 50 pages
Advik Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advik Laboratories Limited engages in the manufacture and sale of pharmaceutical products in India. The company offers ethical and generic drugs in various formulations. Its generic product portfolio...

March 2020 50 pages

Filters

Search

Publishers

1,678
37
1,678
12
2
1
1
21
2
1
1

Regions

1,185
355
328
213
185
145
137
107
77
69
63
63
57
57
41
27
25
20
19
18
17
17
17
17
17
13
11
11
11
10
9
7
7
6
5
5
5
5
5
4
2
2
2
2
2
2
2
2
2
2
2
2
1
19

Price

Date

Pages

Offers